A case of euglycaemic diabetic ketoacidosis in a patient with latent autoimmune diabetes in adults using dapagliflozin.

Promoting insulin as a normal part of the diabetes continuum and a beneficial change for long-term health will further improve patients’ experience during the commencement of insulin.

Glycated haemoglobin (HbA1c) should not be interpreted in isolation; the measurement accuracy and other parameters, including treatment goals and comorbidities, need to be considered.

Sodium–glucose co-transporter-2 inhibitors are becoming a cornerstone of therapy for type 2 diabetes, kidney disease and heart failure.